Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Multiple Myeloma 3Waldenstrom Macroglobulinemia 1Stomach Neoplasms 1Recurrence 1Neoplasms, Second Primary 1Neoplasms 1NSCLC 1Lymphoma, Mantle-Cell 1Immunoglobulin Light-chain Amyloidosis 1

Interventions

sacubitril and valsartan sodium hydrate drug combination 1icotinib 1Thalidomide 1Megestrol Acetate 1Isotretinoin 1Drug Therapy 1Doxycycline 1Docetaxel 1Carboplatin 1Antineoplastic Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Neoplasms, Second Primary × Thalidomide × Clear all
NCT03777930 2018-12-19

The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol

Shenzhen Fifth People's Hospital

Phase 4 Unknown
200 enrolled
Tumor-Agnostic

Neoplasms, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡